ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
82.54
-0.54 (-0.65%)
Jun 5, 2026, 10:26 AM EDT - Market open
BIB Holdings Information
BIB is an equity ETF with a total of 263 individual holdings.
Total Holdings
263
Top 10 Percentage
153.68%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
66.62M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 32.15% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 28.97% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 27.74% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 21.69% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 20.66% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 5.20% |
| 7 | AMGN | Amgen Inc. | 4.69% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 4.68% |
| 9 | GILD | Gilead Sciences, Inc. | 4.56% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.34% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.06% |
| 12 | RVMD | Revolution Medicines, Inc. | 1.58% |
| 13 | BIIB | Biogen Inc. | 1.47% |
| 14 | ILMN | Illumina, Inc. | 1.31% |
| 15 | UTHR | United Therapeutics Corporation | 1.23% |
| 16 | ARGX | argenx SE | 1.22% |
| 17 | RPRX | Royalty Pharma plc | 1.21% |
| 18 | INSM | Insmed Incorporated | 1.16% |
| 19 | ROIV | Roivant Sciences Ltd. | 1.08% |
| 20 | MRNA | Moderna, Inc. | 1.04% |
| 21 | INCY | Incyte Corporation | 1.03% |
| 22 | VTRS | Viatris Inc. | 0.94% |
| 23 | GH | Guardant Health, Inc. | 0.89% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 0.86% |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 0.76% |
As of Jun 4, 2026